In this preliminary study, the results showed that there was an upregulated tendency after treatment with IVIG,, although considerable samples was sustained low expression Linsitinib price of NKG2D, which might be related to relative short time to be revaluated after IVIG therapy. The levels of NKG2D expression on CD3−CD56+NKG2D+ NK cells were increased

in 20 children who received therapy with IVIG. The levels of NKG2D expression on CD8+T cells in 30 children with KD after IVIG treatment were detected to be higher than those before the therapy (shown in Fig. 3). The MFI of NKG2D expression on CD3−CD56+NKG2D+ NK cells was increased in 22 children who received therapy with IVIG. The MFI of NKG2D expression on CD8+T cells in 29 children with KD after IVIG

treatment was detected to be higher than those before the therapy (shown in Fig. 3). Rea1-time PCR was used to evaluate the mRNA levels of cytokines such as IL-1β, IL-6 and TNF-α. As shown in Fig. 4, compared with healthy controls, the expression levels of IL-1β (5.12E-01 ± 1.78E-01 versus 8.85E-02 ± 3.13E-02, t = 14.89, P < 0.05), IL-6 (4.22E-03 ± 2.31E-03 versus 1.72E-03 ± 1.35E-03, t = 5.944, P < 0.05) and TNF-α (1.19E-01 ± 5.12E-02 versus see more 1.16E-02 ± 6.10E-03, t = 13.903, P < 0.05) were significantly upregulated during acute phase of KD. The levels Sclareol of IL-1β (1.06E-01 ± 5.09E-02, t = 13.768, P < 0.05), IL-6 (1.48E-03 ± 8.10E-04,

t = 7.590, P < 0.05) and TNF-α (3.03E-02 ± 2.48E-02, t = 10.469, P < 0.05) expression were decreased to some extents after therapy with IVIG. In addition, transcription levels of proinflammatory cytokines [IL-1β (6.12E-01 ± 2.19E-01 versus 4.59E-01 ± 1.26E-01, t = 2.576, P < 0.05), IL-6 (6.41E-03 ± 1.66E-03 versus 3.05E-03 ± 1.67E-03, t = 2.419, P < 0.05) and TNF-α (1.51E-01 ± 6.74E-02 versus 1.02E-01 ± 3.10E-02, t = 2.757, P < 0.05)] in KD-CAL+ patients with coronary artery lesion were detected to be higher than those in patients with KD-CAL−. It has been reported that IL-7 and IL-15 induce the expression of NKG2D on immunocompetent cells, and NKG2D can be downregulated on these cells by IL-12, TGF-β and IFN-γ [8-12] (Table 4). In this study, the plasma concentration of cytokines in KD was detected by ELISA. The serum concentrations of IL-7 and IL-15 in patients with KD were significantly lower compared with the concentrations in the healthy controls and the KD patients after IVIG therapy (P < 0.05). And the IFN-γ concentration in KD was higher compared with the concentration in the healthy controls and the KD patients after IVIG therapy (P < 0.05). But there were no obvious difference to be found between the patients with KD and the healthy controls in concentrations of IL-12 and TGF-β (P > 0.05) (shown in Table 4). NKG2A is an inhibitory receptor expressed on NK cells and CD8+T cells.